Answers are grounded in this paper and cite their sources.
Retrospective study evaluates first-trimester biomarkers for predicting gestational diabetes, suggesting improved early intervention.
Introduction:The prevalent pregnancy concern, gestational diabetes mellitus (GDM), is marked by intolerance to glucose during the second or third trimester and is detected by oral glucose tolerance testing (OGTT).Gestational diabetes mellitus poses immediate as well as prolonged complications for the mother and the baby.Early identification of high-risk women could facilitate timely intervention.This study evaluated maternal blood indicators [Beta-human chorionic gonadotropin (β-hCG), PAPP-A] in the first trimester, thyroid parameters [thyroid-stimulating hormone (TSH), fT4], and hematological/inflammatory markers for their association with subsequent GDM development. Materials and methods:A retrospective cohort study was carried out at Sri Ramachandra Medical College and Hospital, Chennai, including 241 pregnant women who had first-trimester screening and underwent OGTT.Participants were classified into GDM (n = 65) and control (n = 176) groups.Maternal characteristics and biochemical, thyroid, and hematological markers were analyzed.Statistical analysis included t-tests, logistic regression, and receiver operating characteristic (ROC) analysis using SPSS version 21.Results: First-trimester PAPP-A and β-hCG levels were substantially reduced (p < 0.001) in the GDM group, while maternal weight and glycaemic indices were notably higher.Logistic regression revealed inverse associations between GDM and both PAPP-A [odds ratio (OR) = 0.999] and β-hCG (OR = 0.914), with stronger associations observed for their multiples of the median (MoM) values.Adjusted models confirmed the robustness of these associations.Receiver operating characteristic analysis demonstrated improved predictive accuracy when combining β-hCG and PAPP-A [area under the curve (AUC) = 0.874; specificity = 90.5%],while the MoM combination demonstrated moderate predictive value (AUC = 0.774).Conclusion: Reduced first-trimester levels of PAPP-A and β-hCG are significantly linked to a higher risk of GDM.Their combined assessment may improve early prediction and facilitate timely intervention to enhance maternal and fetal outcomes.Clinical significance: Routine first-trimester measurement of PAPP-A and β-hCG offers a cost-effective opportunity for early GDM risk stratification without additional tests.Integrating them into screening protocols may enable timely intervention.Future priorities include rural access, standardized protocols, and validation through large-scale prospective studies in diverse populations.
No takes yet. Share an insight, caveat, or question.
Senthilkumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: